The aims of this study were (a) to determine if rat alveolar type II (ATIl) cells and human pulmonary epithelial-derived cells (A549 cell line) could generate (b) to characterize the cytokine regulation of IL-6 gene and protein expression in these cells, and (c) to detect the in vivo expression of immunoreactive IL-6 by human ATH cells. Rat ATH cells in primary culture secreted bioactive IL-6 and immunostained with an anti-IL-6 antiserum. Spontaneous IL-6 secretion by rat ATH cells amounted to 5,690±770 pg/ml/106 cells (n = 12) and was fivefold higher than spontaneous rat alveolar macrophages IL-6 secretion (1,052±286 pg/ml/106 cells, n = 8, P = 0.001). Rat alveolar macrophage conditioned media (CM) increased IL-6 secretion by rat ATH cells through the effect of IL-1 and TNF. IL-6 gene expression and IL-6 secretion by A549 cells was induced by 1L-lfi, TNFa, and by human alveolar macrophages and THP1 cells CM. Induction was abolished when CM were preincubated with anti-IL-lfi and anti-TNFa antibody. The combination of IFNy and LPS induced the expression of IL-6 mRNA by A549 cells whereas LPS alone had no effect. Immunohistochemical staining evidenced the expression of immunoreactive 1L-6 by hyperplastic ATHI cells in fibrotic human lung, a condition in which alveolar macrophages are known to be activated. ATII cells in normal human lung did not express immunoreactive 1L-6.
Introduction
Type II alveolar epithelial cells (ATh cells)' have been shown to play a key role in the regulation of the alveolar space. ATh 1. Abbreviations used in this paper: AM, human alveolar macrophage; AM-CM, LPS-stimulated alveolar macrophage-conditioned media; ATH cells, type II alveolar cells; BAL, bronchoalveolar lavage; rh, recombinant human; rm, recombinant murine; THP1-CM, LPS-stimulated THP1 cell-conditioned media. cells synthesize and secrete surfactant, control the volume and composition of the epithelial lining fluid and proliferate and differentiate into type I alveolar epithelial cells after injury in order to maintain the integrity of the alveolar wall (1) . Moreover, ATh cells are ideally located to have a role in modulating immunologic activity in the alveolar space. In this setting, both in vitro and in vivo data suggest that ATH cells could participate in the intra-alveolar cytokine network by secreting interleukin-8 (IL-8) (2), interferon (3), monocyte chemoattractant protein-1 (4), transforming growth factor-beta (5), platelet-derived growth factor (6, 7) , and granulocyte monocyte colony-stimulating factor (8) under appropriate stimulation.
Interleukin-6 (IL-6) is a cytokine involved in the regulation of the immune response and inflammation. Also, IL-6 modulates proliferation of lymphoid and nonlymphoid cells (9) . IL-6 is produced mainly by monocytes (10) but numerous cell types such as fibroblasts (11) , endothelial cells (12) , and epithelial cells (9, 13) can also produce this cytokine. IL-6 is usually thought as a pro-inflammatory cytokine (10) . However, it has been suggested that 1L-6 may act as an inhibitor of local acute inflammation particularly in the lung (14) .
Increased levels of 11L-6 have been detected in the epithelial lining fluid recovered by bronchoalveolar lavage (BAL) in different pathologic conditions ( 15, 16) . Although alveolar macrophages are certainly involved in vivo in the generation of alveolar IL-6 since they are known as potent producers of 11L-6 (17), the possible contribution to IL-6 production by alveolar epithelial cells, particularly AThI cells, is unknown. Therefore this study was designed (a) to determine if rat AThI cells and human pulmonary epithelial-derived cells (A549 cell line) could generate 11L-6 in vitro, (b) to characterize the cytokine regulation of 1L-6 gene and protein expression in vitro, and (c) to assess the in vivo expression of immunoreactive IL-6 by ATII cells in human lung.
Methods
Reagents. Human recombinant (hr) interleukin-lbeta (IL-1,/), tumor necrosis factor alpha (INFa), and IL-6, and murine recombinant (mr) IL-1,6 and TNFa were purchased from Immugenex (Los Angeles, CA).
Human recombinant interferon gamma (IFNy) was a generous gift of Roussel-Uclaf (Romainville, France). Rabbit anti-human TNFa antibody, anti-mouse TNFa antibody and goat anti-human IL-iI antibody (IgG fraction) were from Immugenex. Polyclonal rabbit anti-human IL- 6 antibody and rabbit anti-murine IL-la were obtained from Genzyme (Boston, MA). Phorbol 12-myristate 13-acetate (PMA) was obtained from Sigma Chemical Co. (La Verpilliere, France). Escherichia coli (strain 055: B5)-derived lipopolysaccharide (LPS) was obtained from Difco Laboratories (Detroit, MI) .
Tissue culture media, supplements, and fetal bovine serum were obtained from Flow Labs (Irvine, U.K.) except of MEM non essential amino acids (lOOx) and MEM vitamins (lOOX) which were from Isolation of rat alveolar type II cells andpreparation of rat alveolar macrophage conditioned medium. ATh cells were isolated from adult pathogen-free male Sprague-Dawley rats (Charles River Breeders, St Aubin les Elbeuf, France) by enzymatic dissociation and purified by differential adherence to plastic as previously described (18) . 106 cells were plated in each well of a 24-well cell culture plate with 1 ml of Dulbecco's modified Eagle's medium (DME) containing 10% fetal bovine serum, 105 U/ml penicillin, 100 mg/l streptomycin and 0.25 mg/ 1 amphotericin B (complete DME). After a 24-h period, nonadherent cells were removed by gently washing twice with PBS, fresh complete medium replaced and the cells were used for the experiments. ATh cells were routinely identified by the modified Papanicolaou stain and by phosphine fluorescence staining (19) . 93±2% (mean±SEM, n = 12) adherent cells were ATH cells 20 h after isolation. Adherent cell viability was higher than 98% as assessed by the trypan blue exclusion test. Contaminating cells consisted primarily of alveolar macrophages and fibroblasts.
To recover rat alveolar macrophages, the lungs of rats previously anesthetized with sodium pentobarbital and killed by exsanguination were lavaged ten times with 10 ml sterile PBS. Lavage fluid was collected in 50-ml polypropylene tubes and centrifuged at 600 g for 10 min. The cell pellet was resuspended in RPMI with 10% heat-inactivated fetal bovine serum, with antibiotics and glutamine, at a density of 106 cells/ml. 106 cells were plated in each well of a 24-well cell culture plate and allowed to adhere for 2 h, then nonadherent cells were removed and fresh medium containing 10 jig/ml LPS was added. Adherent cells were more than 98% alveolar macrophages as assessed by non specific esterase stain (Sigma Chemical Co.). Conditioned media of LPS-activated rat AM (rat AM-CM) was recovered after a 24-h incubation period.
Culture of human A549 pulmonary epithelial cells and preparation of human alveolar macrophages conditioned media. To extend to the human the results obtained in the rat model, the A549 pulmonary epithelial cell line was obtained from the American Type Culture Collection (Rockville, MD). The A549 cell line, which is derived from a patient with alveolar cell carcinoma of the lung, has been used as a model of human ATII cells in the literature (2, 4, 20, 21) . We used these cells in this study since centration of 10 ,ug/ml was added. Conditioned media of LPS-stimulated AM (human AM-CM) was recovered after a 24-h incubation period at 37TC. Alternatively, conditioned media was prepared using THP1 cells (THP1-CM), a monocytic cell line, as previously described (22) . Determination of IL-6 concentration in cell culture supernatants. Bioactive IL-6 was measured in rat ATH cell and A549 cell culture supernatants using the IL-6 dependent B9 hybridoma cell line (23) . B9 cells were cultured for 72 h in the presence of duplicate serial dilutions of cell supernatants in 96-well plates. B9 cell proliferation was estimated after 72 h of incubation using the MTT colorimetric assay (24) . hrIL-6 was used as an internal standard in all assays. One reference unit of IL-6 was defined by the half-maximal proliferation of B9 cells. Immunoreactive IL-6 was measured in A549 cell supernatants using a commercially available IL-6 ELISA kit (EASIA; Medgenix, Fleurus, Belgium). This ELISA-kit consistently detected IL-6 concentrations > 10 pg/ml in a linear fashion. Results are expressed as the mean of duplicate assays.
Northern blot analysis. Total cellular RNA from A549 cells grown in 100-mm cell culture dishes and rat ATH cells grown in 25-cm2 cell culture flasks was isolated using the guanidium thiocyanate method (25) . RNA corresponding to 4.106 cells (-20 jsg) was size fractionated by electrophoresis through a 1% agarose gel containing 0.02 mM Lmorpholinopropane sulfonic acid (Mops) buffer and 15% formaldehyde, then transferred to a nitrocellulose/nylon membranes (Amersham, Les Ulis, France), baked, prehybridized, and hybridized with a 32P-labeled plasmid cDNA probe. IL-6 RNA was detected using a 1.1-kb EcoRIBam HI fragment cDNA probe (26) (a generous gift of Dr Aggarwal, USA). Membranes were exposed for 15 d at -800C to Kodak X-OMAT XAR 5 films. Equivalent amounts of total RNA/gel were assessed by monitoring non specific hybridization with 18S rRNA. Autoradiographs were quantified using laser densitometry. The ratio of the IL-6 band density against the 18S rRNA band density was calculated for each lane in order to quantify the 1L-6 mRNA according to the amount of total RNA/gel.
Stimulation of IL-6 secretion by rat ATI cell and A549 cell. Rat ATII cells were used 24 h after isolation. Cells were incubated with complete DME, and cytokines or rat AM-CM was added for the specific times and doses. Supernatants were recovered for bioactive 1L-6 concentration determination. In these experiments, we stimulated rat ATII cells with murine recombinant cytokines since rat products were not available to us. These cytokines have been previously used for this purpose in the literature (27) . In neutralizing studies, CM was pre-incubated overnight at +4°C with constant agitation with rabbit anti-murine TNFa or anti-murine 11L-la antibodies (1 ,ug/ml) or both.
On the day of use, A549 cells were washed twice with PBS and incubated with complete Ham F12 medium, and either cytokines, LPS, AM-, or THP1 cell conditioned media was added for the specific times and doses. Supernatants were recovered for bioactive and/or immunoreactive 11L-6 concentration determination. In neutralizing studies, CM was pre-incubated with goat anti-human IL1P neutralizing antibody or antiTNFa antibody (1 jig/ml) or both.
Comparison of IL-6 secretion by rat ATII cells and rat alveolar macrophages. We compared the secretion of bioactive IL-6 by rat ATH cells and rat alveolar macrophages cultured in similar conditions. 106 alveolar macrophages were cultured for 24 h in 500 IAI RPMI with 5% heat-inactivated fetal bovine serum, antibiotics and glutamine with or without 2 ng/ml recombinant murine IL-1I3. The supernatants were recovered and stored at -20°C until 11L-6 assay. Similarly, 106 rat ATH cells were allowed to adhere on 24-well cell culture plates for 24 h in complete DME with 10% fetal bovine serum. Then the non adherent cells were removed by washing and adherent ATH cells were cultured for 24 h in 500 /A complete DME with 5% heat-inactivated fetal bovine serum with or without 2 ng/ml recombinant murine 1L-1,6. Supernatants were collected for bioactive 1L-6 concentration determination. Then the alveolar macrophages and rat ATH cells were removed with trypsin-EDTA and the cells were counted. The 11L-6 concentration in alveolar macrophages and ATII cell culture supernatants was expressed as pg/ ml/ 106 adherent cells.
Immunohistochemistry for detection of IL-6. To determine whether ATH cells synthesized IL-6 in vivo, a combined 11L-6 immunodetection and alkaline phosphatase activity revelation procedure was applied to the cryostat sections from normal lung biopsies (obtained from four patients undergoing surgical lung resection for a localized lung tumor) and from the lung biopsies from three patients who underwent unilateral lung transplantation for advanced idiopathic interstitial pulmonary fibrosis. All lung biopsies were immediately frozen in nitrogen liquid after resection and stored at -80°C until use. The 11L-6 detection procedure, then the alkaline phosphatase procedure, were applied sequentially. This allowed us to detect on the same section the cells that were anti-IL-6 positive and those that were alkaline phosphatase positive.
Cryostat sections (8 gm) were fixed in acetone for 10 min at room temperature, air dried, rehydrated in PBS, then incubated with a normal goat serum for 5 min to avoid nonspecific binding. Excess serum was tipped off, and lung sections were overlaid for 20 min with a polyclonal rabbit anti-human IL-6 antiserum (1:100 vol/vol in PBS containing 0.1% BSA). After several washes in PBS, lung sections were incubated for 20 min with a biotinylated goat anti-rabbit antibody, then incubated with streptavidin-peroxidase (ICN Biomedicals, Costa Mesa, CA) for 20 min and washed in distilled water. Peroxidase reaction was then revealed by diaminobenzidine (Vector Labs, Burlingame, CA) and H202. Anti-IL-6 positive cells appeared brown. Sections were counterstained with Harris hematoxylin (Ortho Diagnostic Systems, Bucks, England). Sections where the first antibody was omitted or where preimmune rabbit serum was used instead of the anti-IL-6 antibody were used as controls in order to assess the specificity of the immunolabeling.
Type H pneumocytes were characterized according to their alkaline phosphatase activity as previously described by Edelson et al. (28) . A stock solution of enzyme substrate was prepared by dissolving 30 mg of naphtol-AS-phosphate in 0.5 ml of N,N-dimethylformamide (Sigma Chemical Co.) and diluting to 100 ml of 0.2 M Tris buffer previously adjusted to pH 9.1. Immediately before staining, the Fast Blue BB salt (Sigma Chemical Co.) was added to the stock substrate solution (1 mg/ ml) and filtered. After the peroxidase was revealed, the sections were incubated with the staining solution for 45 min at 370C and washed in distilled water. Alkaline phosphatase positive cells appeared blue.
In some experiments, rat ATH cells were grown on coverslips, stimulated with rmIl-l-3 (2 ng/ml) for 24 h then immunostained with the anti-IL-6 antiserum. In preliminary experiments, we observed that the anti-human IL-6 antiserum cross-reacted with rat IL-6 since it neutralized the 11L-6 bioactivity contained in rat alveolar macrophage superna- (Fig. 3) .
Comparison of IL-6 secretion by rat ATII cells and rat alveolar macrophages. To assess the quantitative importance of IL-6 secretion by ATHI cells, we compared IL-6 secretion by rat ATI[ cells with that of rat alveolar macrophages (Fig. 4) . Spontaneous IL-6 secretion by rat ATH cells amounted to 5690±770 pg/ml/106 cells (n = 12) and was fivefold higher than spontaneous rat alveolar macrophages IL-6 secretion (1052±286 pg/ml/106 cells, n = 8, P = 0.001). IL-6 secretion by ATH cells was increased by 48% with IL-1,i stimulation (8486±632 pg/ml/ 106 cells, n = 12, P = 0.01 when compared with spontaneous secretion) and was two-fold higher than IL-1/3 stimulated rat alveolar macrophages IL-6 secretion (3844±566 pg/ml/106 cells, n = 8, P = 0.001). were stimulated for 24 h with either 0.02-20 ng/ml rhIL-lI3 shown in Fig. 5, treatment or rhTNFa. For IL-1p, concentrations as low as 0.02 ng/ml sulted in the production of induced the secretion of bioactive IL-6 in the A549 cell supernaen as early as 1 h, reached tant that was maximal at 0.2 ng/ml and did not further increase. ed. Bioactive IL-6 concenFor TNFa, higher concentrations were needed to observe a *1/3 treated than in TNFadetectable concentration of bioactive IL-6 in A549 cell supernapernatants contained IL-6 tants. Indeed, bioactive IL-6 was consistently detected with 0.2 lit of the assay sensitivity ng/ml TNFa and was maximal with 20 ng/ml TNFa. ilture.
To determine whether IL-6 activity was due to antigenic IL-6, supernatants of TNFa and IL-1O stimulated A549 monolayers were assayed for antigenic IL-6 by ELISA. immunoreactive IL-6 concentrations were significantly increased 2 h after stimulation, were maximal 4 h after stimulation and then plateaued. The maximal stimulation was obtained with 2 ng/ml concentrations of stimulants in the medium. Higher concentrations did not further increase the IL-6 secretion in the A549 cell supernatant. Time-and dose-response curves were similar to that obtained for bioactive IL-6. Immunoreactive IL-6 was not detected in the supernatant of unstimulated A549 cells. Costimulation of A549 cells with IL-13 (2 ng/ml) and IL-I TNFa (2 ng/ml) resulted in an additive response (Fig. 7) . IL-1,63 concentrations as low as 0.2 ng/ml induced a maximal expression of IL-6 mRNA as detected by the Northern blot analysis (Fig. 8) . TNFa stimulated the expression of IL-6 mRNA by A549 cells in a dose-dependent fashion, the threshold concentration causing the expression of IL-6 mRNA was 0.2 ng/ml (Fig. 9) . Induction of A549 cell immunoreactive IL-6 secretion and IL-6 mRNA expression by LPS-stimulated human AM and THPI cell conditioned media. To investigate whether AM or THP1 cell could induce the secretion of IL-6 by A549 cells through the secretion of soluble factors, A549 cells were cultured for 24 h with complete Ham's F12 medium containing 10% LPS stimulated human AM-or THP1-CM. As shown in Fig. 10 , AM-CM strongly increased the concentration of immunoreactive IL-6 in A549 cell supernatants. The stimulation was higher than that observed with maximal stimulating concentrations of IL-1/3 and TNFa (20 ng/ml). This was not due to a direct effect of LPS contained in AM-CM since LPS alone (0.1-100 pug/ ml) had no effect. Preincubation of AM-CM with a goat antihuman IL-1I# neutralizing antibody resulted in a 53±2% reduction in immunoreactive IL-6 in A549 cell supernatants.
We obtained quite similar results when A549 cell were incubated with THPI-conditioned media (Fig. 11 A) . Indeed, the anti-human IL-1,6 antibody decreased the IL-6 concentration by Tinm (hours) Figure 6 . Expression of immunoreactive IL-6 in A549 pulmonary epithelial cell supernatants. IL-6 mRNA induced by THP1 conditioned-media. As shown in Fig. 11 B, pre-incubation of THP1-CM with both anti-IL-1/ and anti-TNFa completely inhibited the expression of steady-state IL-6 mRNA induced by THP1 conditioned-media, whereas each antibody by itself only reduced the steady-state IL-6 mRNA.
Synergic effect of LPS and IFNy on the immunoreactive IL-6 secretion and the expression of steady-state IL-6 mRNA by A549 cells. IFNy is one of the major T cell-derived cytokine involved in the activation of monocytes/macrophages during the initiation of the immune response. We asked whether IFNy could induce the expression of 1L-6 by A549 cell and whether it could cooperate with LPS for this purpose. A549 monolayers were stimulated for 24 hours with LPS (0.1-100 Isg/ml) or IFNy (20 ng/ml) or both. As shown in Fig. 12 A, immunoreactive 11L-6 concentration in supernatants of A549 cells incubated for 24 h with LPS alone was not different of IL-6 concentration measured in unstimulated cell supernatants. In contrast, IFNystimulated A549 cells generated IL-6 and the combination of IFNy and LPS induced a dose-dependent increase of immunoreactive IL-6 in A549 cell supernatants. Similarly, IFNy induced a small expression of IL-6 mRNA, whereas LPS alone did not. However, the combination of IFNy and LPS induced a dose-dependent expression of IL-6 mRNA by A549 cells (Fig. 12 B) .
Clearly, although LPS did not directly stimulate the IL-6 mRNA expression and IL-6 secretion in A549 cell, LPS could influence the magnitude of the stimulation effect of IFNy.
Immunohistochemical staining. To determine whether these in vitro observations could have an in vivo significance, we looked for the expression of immunoreactive IL-6 protein in the alveolar epithelium in the normal human lung and in idiopathic interstitial pulmonary fibrosis, a situation where alveolar macrophages have been shown to be chronically activated.
In normal lung, ATH cells were identified by their accumulation of blue reaction product according to alkaline phosphatase staining. The cells were largely cuboidal in shape and located in alveolar "corners". These cells did not stain with the anti-IL-6 serum in all the sections examined (Fig. 13, A and B) .
By contrast, immunohistochemistry demonstrated the expression of immunoreactive IL-6 by hyperplastic ATH cells in interstitial pulmonary fibrosis (Fig. 13, C and D) . Anti-IL-6 immunostaining colocalized with alkaline phosphatase activity. The specificity of this immunostaining reaction was tested by incubating lung sections with pre-immune rabbit serum instead of rabbit anti-LL-6 antiserum. In these conditions, labeling was abolished. These results were uniform and reproducible in all sections studied from the lung biopsies of the three patients studied.
Discussion
Our study strongly suggests that alveolar epithelial cells may be one potential source of intra-alveolar 1L-6. Indeed, we show that in vitro (a) rat ATTI cells supernatants contain biologically active IL-6 that is highly increased with IL-1p3, TNFa, and AM-CM stimulation, (b) cytokine-stimulated human pulmonary epithelial-derived A549 cells express the 11L-6 gene and generate immunoreactive and bioactive 11L-6 whereas unstimulated A549 cells do not, and (c) in vivo, normal AThI cells do not express immunoreactive 11L-6 whereas hyperplastic alveolar epithelial cells in interstitial pulmonary fibrosis do. This IL-6 secretion by AThI cells is potentially important since it is 2-5-fold higher than alveolar macrophage in vitro 11L-6 secretion on a cell per cell basis. 11L-6 is one of the principal mediators of the acute inflammatory response (29) . 11L-6 is secreted at the site of inflammation but may be detected in the serum of patients at levels higher than those at which this cytokine elicits effects on cells in culture (9) . Measurable levels of 11L-6 have been detected in the epithelial lining fluid of normal subjects, as retrieved by BAL. BAL 11L-6 levels are greatly increased in various lung diseases (15, 16, 30) . This increased 11L-6 level in BAL recovered from patients may be derived from several sources. The first one may be a passive diffusion of 11L-6 from plasma into the epithelial lining fluid since detectable concentrations of IL-6 are present in the serum of patients with infectious and inflammatory diseases (31) . A second source of IL-6 could be a local production by inflammatory and non-inflammatory lung cells. Indeed, alveolar macrophages (22, 32) , lung fibroblasts (32), endothelial cells (12) , and bronchial epithelial cells (33) of the C3 complement component by A549 cell, whereas it had no effect on the C5 component production or total protein synthesis (20) . In the present study, we showed that LPS and IFNy acted synergistically to increase the steady-state level of IL-6 mRNA and the secretion of immunoreactive IL-6 by A549 cell. IFNy has been shown to cooperate with muramyl dipeptide, a constituent of mycobacteria, for IL-6 induction in monocytic cell-lines (35) . Similarly, it has been shown that IFNy is required for TNFa to induce IL-6 expression in human monocytic THP1 cells, whereas no significant induction was obtained with either cytokine alone (36 (44, 45) . In addition, hyperplasia of alveolar epithelial cells is a common finding in lung diseases such as in the fibrotic lung (46) . In these conditions it is highly probable that the ratio of alveolar epithelial cells over alveolar macrophages is increased. Altogether, these data suggest that IL-6 secretion by ATII cells in vivo is quantitatively and biologically significant in the alveolar space. Moreover, it has been shown that alveolar macrophages and ATH cells are located predominantly at alveolar septal junctions, in close proximity to each other (47) . This makes the potential for effective communication between these cell types and suggests that our in vitro results have an in vivo significance.
Cellular communication between immune and non-immune cells is likely an essential process in the initiation, maintenance, and resolution of the intra-alveolar inflammatory response. In this setting, it is worthnoting that 1L-6 has been shown to exert some anti-inflammatory functions. In vitro, at pathologic concentrations, 11L-6 inhibit T cell responses via the activation of macrophages that secrete TGF-16, a cytokine that impairs both T cell and thymocyte proliferation responses (13) . Moreover, 11L-6 downregulates 11-116 and TNFa gene expression in human activated monocytes (48) , modulate the synthesis of a l-antitrypsin in vitro in human mononuclear phagocytes (49) , and induces a dysfunction of natural killer functions of lymphocytes (50) . In vivo, in rats, intra-tracheal 1L-6 partially inhibited the neutrophil alveolitis induced by intra-tracheal LPS (14) .
In summary, the present study demonstrates that when adequately stimulated AThI cells produce IL-6 which could participate in the complex cytokine network within the lung and play an important role in the local immune response of the alveolar space.
